Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Oscar Health, Inc.OSCR · Entity 3582 | Director | June 04, 2026 | June 08, 2026 |
| V F CORPVFC · Entity 3887 | Director | May 22, 2026 | May 28, 2026 |
| Vroom, Inc.VRM · Entity 7212 | Director | January 14, 2025 | March 20, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Oscar Health, Inc.
Report date June 04, 2026 · Filed June 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 82,840 |
Reported balance
After 2026-06-04 transaction · row 1
1 source rowRow 1 · 2026-06-04 · Grant · Acquired 8,475 · Balance 82,840 F1: Consists of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Oscar Health, Inc. (the "Issuer") Class A common stock. The RSUs vest on the earlier to occur of (i) the one-year anniversary of the grant date and (ii) the date of the next annual meeting of stockholders of the Issuer following the grant date, subject to continued service through the applicable vesting date. To the extent vested, the RSUs will be settled in shares of the Issuer's Class A common stock on the earliest of (i) the six-month anniversary of the director's separation from service, death or disability and (ii) within five days following a change in control of the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Oscar Health, Inc. (the "Issuer") Class A common stock. The RSUs vest on the earlier to occur of (i) the one-year anniversary of the grant date and (ii) the date of the next annual meeting of stockholders of the Issuer following the grant date, subject to continued service through the applicable vesting date. To the extent vested, the RSUs will be settled in shares of the Issuer's Class A common stock on the earliest of (i) the six-month anniversary of the director's separation from service, death or disability and (ii) within five days following a change in control of the Issuer.
V F CORP
Report date May 22, 2026 · Filed May 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 53,933.733 |
Reported balance
After 2026-05-22 transaction · row 1
1 source rowRow 1 · 2026-05-22 · Grant · Acquired 11,977 · Balance 53,933.733 |
Vroom, Inc.
Report date January 14, 2025 · Filed March 20, 2025 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Warrants (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $60.95 · Expires 2030-01-14 | Direct | 246 |
Reported balance
After 2025-01-14 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2025-01-14 · Grant · Acquired 246 · Balance 246 F1: This amendment is being filed only to correct the grant date originally reported on the Form 4 filed on March 14, 2025. F2: The warrants were issued to stockholders of the Issuer in connection with the Issuer's emergence from bankruptcy on January 14, 2025 (the "Recapitalization"). Each Warrant was immediately exercisable upon issuance. |
Filing footnotes · ownership attribution and instrument terms
F1: This amendment is being filed only to correct the grant date originally reported on the Form 4 filed on March 14, 2025.
F2: The warrants were issued to stockholders of the Issuer in connection with the Issuer's emergence from bankruptcy on January 14, 2025 (the "Recapitalization"). Each Warrant was immediately exercisable upon issuance.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 04, 2026 Filed Jun 8, 2026 20:18 UTC | Oscar Health, Inc. OSCR · Entity 3582 | GrantClass A Common Stock | 8,475 | $0.00 | $0.00 |
DisclosureSEC source: 0001568651-26-000057 · wk-form4_1780949920.xml · nonDerivative · entry 1 Lang Laura W · CIK 0001296589 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,840 F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Oscar Health, Inc. (the "Issuer") Class A common stock. The RSUs vest on the earlier to occur of (i) the one-year anniversary of the grant date and (ii) the date of the next annual meeting of stockholders of the Issuer following the grant date, subject to continued service through the applicable vesting date. To the extent vested, the RSUs will be settled in shares of the Issuer's Class A common stock on the earliest of (i) the six-month anniversary of the director's separation from service, death or disability and (ii) within five days following a change in control of the Issuer. Read SEC document |
| May 22, 2026 Filed May 28, 2026 00:06 UTC | V F CORP VFC · Entity 3887 | GrantCommon Stock | 11,977 | $16.70 | $200,015.90 |
DisclosureSEC source: 0000103379-26-000039 · form4.xml · nonDerivative · entry 1 Lang Laura W · CIK 0001296589 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,933.733 Read SEC document |
| June 04, 2025 Filed Jun 7, 2025 00:01 UTC | V F CORP VFC · Entity 3887 | GrantCommon Stock | 13,285 | $12.55 | $166,726.75 |
DisclosureSEC source: 0001127602-25-017025 · form4.xml · nonDerivative · entry 1 Lang Laura W · CIK 0001296589 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,457.861 Read SEC document |
| June 04, 2025 Filed Jun 6, 2025 20:23 UTC | Oscar Health, Inc. OSCR · Entity 3582 | GrantClass A Common Stock | 14,134 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-004567 · primarydocument.xml · nonDerivative · entry 1 Lang Laura W · CIK 0001296589 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,365 F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Oscar Health, Inc. (the "Issuer") Class A common stock. The RSUs vest on the earlier to occur of (i) the one-year anniversary of the grant date and (ii) the date of the next annual meeting of stockholders of the Issuer following the grant date, subject to continued service through the applicable vesting date. To the extent vested, the RSUs will be settled in shares of the Issuer's Class A common stock on the earliest of (i) the six-month anniversary of the director's separation from service, death or disability and (ii) within five days following a change in control of the Issuer. Read SEC document |
| March 12, 2025 Filed Mar 15, 2025 01:46 UTC | Vroom, Inc. VRM · Entity 7212 | GrantWarrants (Right to buy) · Derivative | 246 | $60.95 Strike: $60.95 | $14,993.70 |
DisclosureSEC source: 0001562180-25-002435 · primarydocument.xml · derivative · entry 2 Lang Laura W · CIK 0001296589 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 246 Underlying: Common Stock · 246 shares Expires 2030-01-14 F3 · shares: The warrants were issued to stockholders of the Issuer in connection with the Recapitalization. Each warrant was immediately exercisable upon issuance. Read SEC document |
| March 12, 2025 Filed Mar 15, 2025 01:46 UTC | Vroom, Inc. VRM · Entity 7212 | GrantCommon Stock | 3,820 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-002435 · primarydocument.xml · nonDerivative · entry 1 Lang Laura W · CIK 0001296589 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,310 F1 · shares: Represents an award of restricted stock units ("RSUs") that vests in full on the earlier of (i) the day immediately preceding the date of the Issuer's first annual meeting of stockholders following the date of grant and (ii) March 12, 2026. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. F2 · balance_after: The number of shares of common stock in this Form 4 reflects the automatic conversion of the prior common stock at a ratio of 1-for-5 in connection with the Issuer's emergence from bankruptcy on January 12, 2025 (the "Recapitalization"). Read SEC document |
| January 14, 2025 Filed Mar 20, 2025 20:14 UTC Amendment | Vroom, Inc. VRM · Entity 7212 | GrantWarrants (Right to buy) · Derivative | 246 | $60.95 Strike: $60.95 | $14,993.70 |
DisclosureSEC source: 0001562180-25-002629 · primarydocument.xml · derivative · entry 1 Lang Laura W · CIK 0001296589 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 246 Underlying: Common Stock · 246 shares Expires 2030-01-14 F1 · date: This amendment is being filed only to correct the grant date originally reported on the Form 4 filed on March 14, 2025. F2 · shares: The warrants were issued to stockholders of the Issuer in connection with the Issuer's emergence from bankruptcy on January 14, 2025 (the "Recapitalization"). Each Warrant was immediately exercisable upon issuance. Read SEC document |
| June 06, 2024 Filed Jun 10, 2024 20:26 UTC | Oscar Health, Inc. OSCR · Entity 3582 | GrantClass A Common Stock | 8,974 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-004918 · primarydocument.xml · nonDerivative · entry 1 Lang Laura W · CIK 0001296589 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,231 F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Oscar Health, Inc. (the "Issuer") Class A common stock. The RSUs vest on the earlier to occur of (i) the one-year anniversary of the grant date and (ii) the date of the next annual meeting of stockholders of the Issuer following the grant date, subject to continued service through the applicable vesting date. To the extent vested, RSUs will be settled in shares of the Issuer's Class A common stock within 45 days following the earliest to occur of: (i) the director's separation from service; (ii) a change in control of the Issuer; (iii) the director's death; or (iv) the director's disability. Read SEC document |
| May 28, 2024 Filed May 31, 2024 01:24 UTC | V F CORP VFC · Entity 3887 | GrantFY 2025 Non-qualified Stock Option (Right to Buy) · Derivative | 18,256 | $0.00 Strike: $12.35 | $0.00 |
DisclosureSEC source: 0001127602-24-017068 · form4.xml · derivative · entry 2 Lang Laura W · CIK 0001296589 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,256 Underlying: Common Stock · 18,256 shares Expires 2034-05-27 Read SEC document |
| May 28, 2024 Filed May 31, 2024 01:24 UTC | V F CORP VFC · Entity 3887 | GrantCommon Stock | 7,288 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017068 · form4.xml · nonDerivative · entry 1 Lang Laura W · CIK 0001296589 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,021.486 Read SEC document |
| June 15, 2023 Filed Jun 20, 2023 20:11 UTC | Vroom, Inc. VRM · Entity 7212 | GrantCommon Stock | 97,656 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-005342 · primarydocument.xml · nonDerivative · entry 1 Lang Laura W · CIK 0001296589 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 211,394 F1 · shares: Represents an award of restricted stock units that vest in full on the earlier of the day immediately preceding the date of the Issuer's first annual meeting of stockholders following the date of grant and June 15, 2024. Each restricted stock unit represents a contingent right to receive one share of Common Stock of the Issuer. The Reporting Person has deferred settlement of the restricted stock units into Common Stock until the earliest to occur of the Reporting Person's separation from service, a change in control of the Issuer, or the Reporting Person's death or disability. Read SEC document |
| June 08, 2023 Filed Jun 12, 2023 20:16 UTC | Oscar Health, Inc. OSCR · Entity 3582 | GrantClass A Common Stock | 19,751 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-005076 · primarydocument.xml · nonDerivative · entry 1 Lang Laura W · CIK 0001296589 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,257 F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Oscar Health, Inc. (the "Issuer") Class A common stock. The RSUs vest on the earlier to occur of (i) the one-year anniversary of the grant date and (ii) the date of the next annual meeting of stockholders of the Issuer following the grant date, subject to continued service through the applicable vesting date. To the extent vested, RSUs will be settled in shares of the Issuer's Class A common stock within 45 days following the earliest to occur of: (i) the director's separation from service; (ii) a change in control of the Issuer; (iii) the director's death; or (iv) the director's disability. Read SEC document |
| May 26, 2023 Filed May 31, 2023 18:13 UTC | V F CORP VFC · Entity 3887 | GrantFY 2024 Non-qualified Stock Option (Right to Buy) · Derivative | 15,733 | $0.00 Strike: $17.95 | $0.00 |
DisclosureSEC source: 0001127602-23-017144 · form4.xml · derivative · entry 2 Lang Laura W · CIK 0001296589 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,733 Underlying: Common Stock · 15,733 shares Expires 2033-05-25 Read SEC document |
| May 26, 2023 Filed May 31, 2023 18:13 UTC | V F CORP VFC · Entity 3887 | GrantCommon Stock | 5,014 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-017144 · form4.xml · nonDerivative · entry 1 Lang Laura W · CIK 0001296589 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,513.937 Read SEC document |
| December 07, 2022 Filed Dec 9, 2022 21:26 UTC | Oscar Health, Inc. OSCR · Entity 3582 | GrantClass A Common Stock | 31,506 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-008185 · primarydocument.xml · nonDerivative · entry 1 Lang Laura W · CIK 0001296589 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,506 F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Oscar Health, Inc. (the "Issuer") Class A common stock. The RSUs vest on the earlier to occur of (i) the one-year anniversary of the grant date and (ii) the date of the next annual meeting of stockholders of the Issuer following the grant date, subject to continued service through the applicable vesting date. To the extent vested, RSUs will be settled in shares of the Issuer's Class A common stock within 45 days following the earliest to occur of: (i) the director's separation from service; (ii) a change in control of the Issuer; (iii) the director's death; or (iv) the director's disability. Read SEC document |
| December 07, 2022 Filed Dec 9, 2022 21:03 UTC | Vroom, Inc. VRM · Entity 7212 | SaleCommon Stock | 7,204 | $0.99 | $7,137.00 |
DisclosureSEC source: 0001562180-22-008180 · primarydocument.xml · nonDerivative · entry 1 Lang Laura W · CIK 0001296589 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,738 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.9824 to $0.996. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 16, 2022 Filed Jun 21, 2022 23:57 UTC | Vroom, Inc. VRM · Entity 7212 | GrantCommon Stock | 81,967 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-005262 · primarydocument.xml · nonDerivative · entry 1 Lang Laura W · CIK 0001296589 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,942 F1 · shares: Represents an award of restricted stock units that vest in full on the earlier of the day immediately preceding the date of the Issuer's first annual meeting of stockholders following the date of grant and June 16, 2023. Each restricted stock unit represents a contingent right to receive one share of Common Stock of the Issuer. Read SEC document |
| June 02, 2022 Filed Jun 6, 2022 20:16 UTC | Vroom, Inc. VRM · Entity 7212 | PurchaseCommon Stock | 15,000 | $1.32 | $19,800.00 |
DisclosureSEC source: 0001562180-22-004838 · primarydocument.xml · nonDerivative · entry 1 Lang Laura W · CIK 0001296589 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,975 Read SEC document |
| May 24, 2022 Filed May 26, 2022 18:19 UTC | V F CORP VFC · Entity 3887 | GrantFY 2023 Non-qualified Stock Option (Right to Buy) · Derivative | 6,662 | $0.00 Strike: $45.34 | $0.00 |
DisclosureSEC source: 0001127602-22-015751 · form4.xml · derivative · entry 2 Lang Laura W · CIK 0001296589 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,662 Underlying: Common Stock · 6,662 shares Expires 2032-05-23 Read SEC document |
| May 24, 2022 Filed May 26, 2022 18:19 UTC | V F CORP VFC · Entity 3887 | GrantCommon Stock | 1,986 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-015751 · form4.xml · nonDerivative · entry 1 Lang Laura W · CIK 0001296589 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,383.572 Read SEC document |
| December 09, 2021 Filed Dec 10, 2021 21:41 UTC | V F CORP VFC · Entity 3887 | Exercise / conversion2012 Non-qualified Stock Option (Right to Buy) · Derivative | 7,429 | $0.00 Strike: $33.81 | $0.00 |
DisclosureSEC source: 0001127602-21-030722 · form4.xml · derivative · entry 3 Lang Laura W · CIK 0001296589 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,429 shares Expires 2022-02-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 09, 2021 Filed Dec 10, 2021 21:41 UTC | V F CORP VFC · Entity 3887 | SaleCommon Stock | 7,429 | $76.40 | $567,575.60 |
DisclosureSEC source: 0001127602-21-030722 · form4.xml · nonDerivative · entry 2 Lang Laura W · CIK 0001296589 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,379.716 F1 · price: The price reported is a weighted average. These shares were sold in multiple transactions at prices ranging from not less than $76.40 to not more than $76.43. The reporting person undertakes to provide to VF Corporation, any security holder of VF Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| December 09, 2021 Filed Dec 10, 2021 21:41 UTC | V F CORP VFC · Entity 3887 | Exercise / conversionCommon Stock | 7,429 | $33.81 | $251,144.77 |
DisclosureSEC source: 0001127602-21-030722 · form4.xml · nonDerivative · entry 1 Lang Laura W · CIK 0001296589 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,808.716 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 24, 2021 Filed Jun 28, 2021 21:51 UTC | Vroom, Inc. VRM · Entity 7212 | GrantCommon Stock | 2,367 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-004534 · primarydocument.xml · nonDerivative · entry 1 Lang Laura W · CIK 0001296589 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,975 F1 · shares: Represents an award of restricted stock units that vest in full on the earlier of the day immediately preceding the date of the Issuer's first annual meeting of stockholders following the date of grant and June 24, 2022. Each restricted stock unit represents a contingent right to receive one share of Common Stock of the Issuer. F2 · balance_after: The securities reported herein have been adjusted to reflect a 2-for-1 forward stock split of the Issuer's common stock that occurred on June 11, 2020. Read SEC document |
| May 25, 2021 Filed May 27, 2021 19:05 UTC | V F CORP VFC · Entity 3887 | GrantFY 2022 Non-qualified Stock Option (Right to Buy) · Derivative | 4,217 | $0.00 Strike: $77.78 | $0.00 |
DisclosureSEC source: 0001127602-21-018151 · form4.xml · derivative · entry 2 Lang Laura W · CIK 0001296589 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,217 Underlying: Common Stock · 4,217 shares Expires 2031-05-24 Read SEC document |
| May 25, 2021 Filed May 27, 2021 19:05 UTC | V F CORP VFC · Entity 3887 | GrantCommon Stock | 1,093 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018151 · form4.xml · nonDerivative · entry 1 Lang Laura W · CIK 0001296589 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,365.131 Read SEC document |
| May 19, 2020 Filed May 21, 2020 21:31 UTC | V F CORP VFC · Entity 3887 | GrantFY 2021 Non-qualified Stock Option (Right to Buy) · Derivative | 5,383 | $0.00 Strike: $55.74 | $0.00 |
DisclosureSEC source: 0001127602-20-017597 · form4.xml · derivative · entry 2 Lang Laura W · CIK 0001296589 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,383 Underlying: Common Stock · 5,383 shares Expires 2030-05-18 Read SEC document |
| May 19, 2020 Filed May 21, 2020 21:31 UTC | V F CORP VFC · Entity 3887 | GrantCommon Stock | 1,525 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-017597 · form4.xml · nonDerivative · entry 1 Lang Laura W · CIK 0001296589 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,231.245 Read SEC document |
| May 24, 2019 Filed May 29, 2019 17:52 UTC | V F CORP VFC · Entity 3887 | GrantFY 2020 Non-qualified Stock Option (Right to Buy) · Derivative | 4,613 | $0.00 Strike: $84.37 | $0.00 |
DisclosureSEC source: 0001127602-19-020109 · form4.xml · derivative · entry 2 Lang Laura W · CIK 0001296589 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,613 Underlying: Commom Stock · 4,613 shares Expires 2029-05-23 Read SEC document |
| May 24, 2019 Filed May 29, 2019 17:52 UTC | V F CORP VFC · Entity 3887 | GrantCommon Stock | 978 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020109 · form4.xml · nonDerivative · entry 1 Lang Laura W · CIK 0001296589 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,680.136 Read SEC document |
| May 24, 2019 Filed Jun 28, 2019 21:11 UTC Amendment | V F CORP VFC · Entity 3887 | GrantFY 2020 Non-qualified Stock Option (Right to Buy) · Derivative | 4,842 | $0.00 Strike: $84.23 | $0.00 |
DisclosureSEC source: 0001127602-19-023059 · form4a.xml · derivative · entry 2 Lang Laura W · CIK 0001296589 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,842 Underlying: Commom Stock · 4,842 shares Expires 2029-05-23 F2 · derivative.exercise_price: This amended Form 4 corrects (i) the number of stock options granted to the reporting person on May 24, 2019 from 4,613 to 4,842 and (ii) the exercise price of such stock options from $84.37 to $84.23. F2 · shares: This amended Form 4 corrects (i) the number of stock options granted to the reporting person on May 24, 2019 from 4,613 to 4,842 and (ii) the exercise price of such stock options from $84.37 to $84.23. Read SEC document |
| May 24, 2019 Filed Jun 28, 2019 21:11 UTC Amendment | V F CORP VFC · Entity 3887 | GrantCommon Stock | 980 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-023059 · form4a.xml · nonDerivative · entry 1 Lang Laura W · CIK 0001296589 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,682.136 F1 · shares: This amended Form 4 corrects the number of restricted stock units granted to the reporting person on May 24, 2019 from 978 to 980. Read SEC document |
| December 28, 2018 Filed Jan 2, 2019 16:55 UTC | V F CORP VFC · Entity 3887 | GrantPhantom Stock-d · Derivative | 335.5231 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-000039 · form4.xml · derivative · entry 1 Lang Laura W · CIK 0001296589 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,617.0763 Underlying: Common Stock · 335.5231 shares Expires not disclosed F1 · security: Represents phantom stock units ("PSUs") accrued under the VF Corporation Directors Deferred Savings Plan ("Plan"), to be settled 100% in cash upon the reporting person's retirement. The number of PSUs acquired equals the amount of Directors' fees deferred by the reporting person divided by the fair market value (average of the high and low selling prices) per share on the date of deferral. The number of PSUs beneficially owned may vary over time due to deemed reinvestment of dividends. F2 · derivative.exercise_price: 1 for 1 F1 · shares: Represents phantom stock units ("PSUs") accrued under the VF Corporation Directors Deferred Savings Plan ("Plan"), to be settled 100% in cash upon the reporting person's retirement. The number of PSUs acquired equals the amount of Directors' fees deferred by the reporting person divided by the fair market value (average of the high and low selling prices) per share on the date of deferral. The number of PSUs beneficially owned may vary over time due to deemed reinvestment of dividends. F4 · price: Each PSU was acquired at the election of the Director by deferring $70.7850 of fees per PSU. F3 · derivative.exercise_date: There is no date that should appear in these columns. These columns are not applicable to this particular filing. F3 · derivative.expiration_date: There is no date that should appear in these columns. These columns are not applicable to this particular filing. Read SEC document |
| September 28, 2018 Filed Oct 1, 2018 17:04 UTC | V F CORP VFC · Entity 3887 | GrantPhantom Stock-d · Derivative | 253.8614 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-028678 · form4.xml · derivative · entry 1 Lang Laura W · CIK 0001296589 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,256.5072 Underlying: Common Stock · 253.8614 shares Expires not disclosed F1 · security: Represents phantom stock units ("PSUs") accrued under the VF Corporation Directors Deferred Savings Plan ("Plan"), to be settled 100% in cash upon the reporting person's retirement. The number of PSUs acquired equals the amount of Directors' fees deferred by the reporting person divided by the fair market value (average of the high and low selling prices) per share on the date of deferral. The number of PSUs beneficially owned may vary over time due to deemed reinvestment of dividends. F2 · derivative.exercise_price: 1 for 1 F1 · shares: Represents phantom stock units ("PSUs") accrued under the VF Corporation Directors Deferred Savings Plan ("Plan"), to be settled 100% in cash upon the reporting person's retirement. The number of PSUs acquired equals the amount of Directors' fees deferred by the reporting person divided by the fair market value (average of the high and low selling prices) per share on the date of deferral. The number of PSUs beneficially owned may vary over time due to deemed reinvestment of dividends. F4 · price: Each PSU was acquired at the election of the Director by deferring $93.5550 of fees per PSU. F3 · derivative.exercise_date: There is no date that should appear in these columns. These columns are not applicable to this particular filing. F3 · derivative.expiration_date: There is no date that should appear in these columns. These columns are not applicable to this particular filing. Read SEC document |
| June 29, 2018 Filed Jul 2, 2018 18:08 UTC | V F CORP VFC · Entity 3887 | GrantPhantom Stock-d · Derivative | 288.5784 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-022117 · form4.xml · derivative · entry 1 Lang Laura W · CIK 0001296589 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,977.0999 Underlying: Common Stock · 288.5784 shares Expires not disclosed F1 · security: Represents phantom stock units ("PSUs") accrued under the VF Corporation Directors Deferred Savings Plan ("Plan"), to be settled 100% in cash upon the reporting person's retirement. The number of PSUs acquired equals the amount of Directors' fees deferred by the reporting person divided by the fair market value (average of the high and low selling prices) per share on the date of deferral. The number of PSUs beneficially owned may vary over time due to deemed reinvestment of dividends. F2 · derivative.exercise_price: 1 for 1 F1 · shares: Represents phantom stock units ("PSUs") accrued under the VF Corporation Directors Deferred Savings Plan ("Plan"), to be settled 100% in cash upon the reporting person's retirement. The number of PSUs acquired equals the amount of Directors' fees deferred by the reporting person divided by the fair market value (average of the high and low selling prices) per share on the date of deferral. The number of PSUs beneficially owned may vary over time due to deemed reinvestment of dividends. F4 · price: Each PSU was acquired at the election of the Director by deferring $82.30 of fees per PSU. F3 · derivative.exercise_date: There is no date that should appear in these columns. These columns are not applicable to this particular filing. F3 · derivative.expiration_date: There is no date that should appear in these columns. These columns are not applicable to this particular filing. Read SEC document |
| March 30, 2018 Filed Apr 2, 2018 16:29 UTC | V F CORP VFC · Entity 3887 | GrantPhantom Stock-d · Derivative | 318.7599 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-013190 · form4.xml · derivative · entry 1 Lang Laura W · CIK 0001296589 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,661.645 Underlying: Common Stock · 318.7599 shares Expires not disclosed F1 · security: Represents phantom stock units ("PSUs") accrued under the VF Corporation Directors Deferred Savings Plan ("Plan"), to be settled 100% in cash upon the reporting person's retirement. The number of PSUs acquired equals the amount of Directors' fees deferred by the reporting person divided by the fair market value (average of the high and low selling prices) per share on the date of deferral. The number of PSUs beneficially owned may vary over time due to deemed reinvestment of dividends. F2 · derivative.exercise_price: 1 for 1 F1 · shares: Represents phantom stock units ("PSUs") accrued under the VF Corporation Directors Deferred Savings Plan ("Plan"), to be settled 100% in cash upon the reporting person's retirement. The number of PSUs acquired equals the amount of Directors' fees deferred by the reporting person divided by the fair market value (average of the high and low selling prices) per share on the date of deferral. The number of PSUs beneficially owned may vary over time due to deemed reinvestment of dividends. F4 · price: Each PSU was acquired at the election of the Director by deferring $74.5075 of fees per PSU. F3 · derivative.exercise_date: There is no date that should appear in these columns. These columns are not applicable to this particular filing. F3 · derivative.expiration_date: There is no date that should appear in these columns. These columns are not applicable to this particular filing. Read SEC document |
| February 21, 2018 Filed Feb 23, 2018 17:49 UTC | V F CORP VFC · Entity 3887 | Grant2018 Non-qualified Stock Option (Right to Buy) · Derivative | 5,404 | $74.80 Strike: $74.80 | $404,219.20 |
DisclosureSEC source: 0001127602-18-007965 · form4.xml · derivative · entry 2 Lang Laura W · CIK 0001296589 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,404 Underlying: Commom Stock · 5,404 shares Expires 2028-02-20 Read SEC document |
| February 21, 2018 Filed Feb 23, 2018 17:49 UTC | V F CORP VFC · Entity 3887 | GrantCommon Stock | 1,655 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-007965 · form4.xml · nonDerivative · entry 1 Lang Laura W · CIK 0001296589 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,662.35 Read SEC document |
| February 22, 2017 Filed Feb 24, 2017 20:07 UTC | V F CORP VFC · Entity 3887 | Grant2017 Non-Qualified Stock Option (right to buy) · Derivative | 8,110 | $0.00 Strike: $53.47 | $0.00 |
DisclosureSEC source: 0001246360-17-000981 · form.xml · derivative · entry 2 Lang Laura W · CIK 0001296589 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,110 Underlying: Common Stock · 8,110 shares Expires 2027-02-21 Read SEC document |
| February 22, 2017 Filed Feb 24, 2017 20:07 UTC | V F CORP VFC · Entity 3887 | GrantCommon Stock | 1,497 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-17-000981 · form.xml · nonDerivative · entry 1 Lang Laura W · CIK 0001296589 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,939 Read SEC document |
| December 30, 2016 Filed Jan 3, 2017 19:35 UTC | V F CORP VFC · Entity 3887 | GrantPhantom Stock-D · Derivative | 420.1681 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-17-000017 · form.xml · derivative · entry 1 Lang Laura W · CIK 0001296589 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,193.475 Underlying: Common Stock · 420.1681 shares Expires not disclosed F1 · security: Represents phantom stock units ("PSUs") accrued under the VF Corporation Directors Deferred Savings Plan ("Plan"), to be settled 100% in cash upon the reporting person's retirement. The number of PSUs acquired equals the amount of Directors' fees deferred by the reporting person divided by the fair market value (average of the high and low selling prices) per share on the date of deferral. The number of PSUs beneficially owned may vary over time due to deemed reinvestment of dividends. F2 · derivative.exercise_price: 1 for 1 F1 · shares: Represents phantom stock units ("PSUs") accrued under the VF Corporation Directors Deferred Savings Plan ("Plan"), to be settled 100% in cash upon the reporting person's retirement. The number of PSUs acquired equals the amount of Directors' fees deferred by the reporting person divided by the fair market value (average of the high and low selling prices) per share on the date of deferral. The number of PSUs beneficially owned may vary over time due to deemed reinvestment of dividends. F3 · price: Each PSU was acquired at the election of the Director by deferring $53.55 of fees per PSU. F4 · derivative.exercise_date: There is no date that should appear in these columns. These columns are not applicable to this particular filing. F4 · derivative.expiration_date: There is no date that should appear in these columns. These columns are not applicable to this particular filing. Read SEC document |
| September 30, 2016 Filed Oct 3, 2016 17:07 UTC | V F CORP VFC · Entity 3887 | GrantPhantom Stock-D · Derivative | 401.2483 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-16-006864 · form.xml · derivative · entry 1 Lang Laura W · CIK 0001296589 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,751.4084 Underlying: Common Stock · 401.2483 shares Expires not disclosed F1 · security: Represents phantom stock units ("PSUs") accrued under the VF Corporation Directors Deferred Savings Plan ("Plan"), to be settled 100% in cash upon the reporting person's retirement. The number of PSUs acquired equals the amount of Directors' fees deferred by the reporting person divided by the fair market value (average of the high and low selling prices) per share on the date of deferral. The number of PSUs beneficially owned may vary over time due to deemed reinvestment of dividends. F2 · derivative.exercise_price: 1 for 1 F1 · shares: Represents phantom stock units ("PSUs") accrued under the VF Corporation Directors Deferred Savings Plan ("Plan"), to be settled 100% in cash upon the reporting person's retirement. The number of PSUs acquired equals the amount of Directors' fees deferred by the reporting person divided by the fair market value (average of the high and low selling prices) per share on the date of deferral. The number of PSUs beneficially owned may vary over time due to deemed reinvestment of dividends. F3 · price: Each PSU was acquired at the election of the Director by deferring $56.0750 of fees per PSU. F4 · derivative.exercise_date: There is no date that should appear in these columns. These columns are not applicable to this particular filing. F4 · derivative.expiration_date: There is no date that should appear in these columns. These columns are not applicable to this particular filing. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.